2Q7R

Crystal structure of human FLAP with an iodinated analog of MK-591


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 4.00 Å
  • R-Value Free: 0.281 
  • R-Value Work: 0.268 
  • R-Value Observed: 0.268 

wwPDB Validation   3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein.

Ferguson, A.D.McKeever, B.M.Xu, S.Wisniewski, D.Miller, D.K.Yamin, T.T.Spencer, R.H.Chu, L.Ujjainwalla, F.Cunningham, B.R.Evans, J.F.Becker, J.W.

(2007) Science 317: 510-512

  • DOI: 10.1126/science.1144346
  • Primary Citation of Related Structures:  
    2Q7M, 2Q7R

  • PubMed Abstract: 
  • Leukotrienes are proinflammatory products of arachidonic acid oxidation by 5-lipoxygenase that have been shown to be involved in respiratory and cardiovascular diseases. The integral membrane protein FLAP is essential for leukotriene biosynthesis. We describe the x-ray crystal structures of human FLAP in complex with two leukotriene biosynthesis inhibitors at 4 ...

    Leukotrienes are proinflammatory products of arachidonic acid oxidation by 5-lipoxygenase that have been shown to be involved in respiratory and cardiovascular diseases. The integral membrane protein FLAP is essential for leukotriene biosynthesis. We describe the x-ray crystal structures of human FLAP in complex with two leukotriene biosynthesis inhibitors at 4.0 and 4.2 angstrom resolution, respectively. The structures show that inhibitors bind in membrane-embedded pockets of FLAP, which suggests how these inhibitors prevent arachidonic acid from binding to FLAP and subsequently being transferred to 5-lipoxygenase, thereby preventing leukotriene biosynthesis. This structural information provides a platform for the development of therapeutics for respiratory and cardiovascular diseases.


    Organizational Affiliation

    Department of Medicinal Chemistry, Merck Research Laboratories, Rahway, NJ 07065, USA.



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Arachidonate 5-lipoxygenase-activating proteinA, B, C, D, E, F161Homo sapiensMutation(s): 4 
Gene Names: ALOX5APFLAP
Membrane protein
Mpstruc
Group: 
TRANSMEMBRANE PROTEINS: ALPHA-HELICAL
Sub Group: 
Membrane-Associated Proteins in Eicosanoid and Glutathione Metabolism (MAPEG)
Protein: 
5-Lipoxygenase-Activating Protein (FLAP) with Bound MK-591 Inhibitor
Find proteins for P20292 (Homo sapiens)
Explore P20292 
Go to UniProtKB:  P20292
NIH Common Fund Data Resources
PHAROS:  P20292
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
3CS
Query on 3CS

Download Ideal Coordinates CCD File 
G [auth A], H [auth B], I [auth C], J [auth D], K [auth E], L [auth F]3-[3-(3,3-DIMETHYLBUTANOYL)-1-(4-IODOBENZYL)-5-(QUINOLIN-2-YLMETHOXY)-1H-INDOL-2-YL]-2,2-DIMETHYLPROPANOIC ACID
C36 H37 I N2 O4
VRDARPDCOSVXDY-UHFFFAOYSA-N
 Ligand Interaction
Modified Residues  1 Unique
IDChainsTypeFormula2D DiagramParent
MSE
Query on MSE
A, B, C, D, E, FL-PEPTIDE LINKINGC5 H11 N O2 SeMET
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 4.00 Å
  • R-Value Free: 0.281 
  • R-Value Work: 0.268 
  • R-Value Observed: 0.268 
  • Space Group: P 4 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 180.66α = 90
b = 180.66β = 90
c = 139.99γ = 90
Software Package:
Software NamePurpose
BUSTER-TNTrefinement
HKL-2000data reduction
HKL-2000data scaling
SHARPphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

  • Deposited Date: 2007-06-07 
  • Released Date: 2007-08-21 
  • Deposition Author(s): Ferguson, A.D.

Revision History  (Full details and data files)

  • Version 1.0: 2007-08-21
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Version format compliance